Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 11.47M
June 30, 2026 0.6683M
March 31, 2026 0.6671M
December 31, 2025 0.6665M
September 30, 2025 0.6355M
June 30, 2025 0.3955M
March 31, 2025 0.3192M
December 31, 2024 14.83M
September 30, 2024 14.75M
June 30, 2024 14.54M
March 31, 2024 14.30M
December 31, 2023 14.10M
September 30, 2023 3.305M
June 30, 2023 3.282M
March 31, 2023 3.271M
December 31, 2022 3.230M
September 30, 2022 3.224M
June 30, 2022 3.222M
March 31, 2022 3.217M
December 31, 2021 0.0595M
Date Value
September 30, 2021 0.0595M
June 30, 2021 0.0572M
March 31, 2021 0.0571M
December 31, 2020 2.400M
September 30, 2020 2.331M
June 30, 2020 2.329M
March 31, 2020 0.8542M
December 31, 2019 0.0101M
September 30, 2019 0.0067M
June 30, 2019 0.0067M
March 31, 2019 0.0066M
December 31, 2018 0.3227M
September 30, 2018 0.3227M
June 30, 2018 0.3191M
March 31, 2018 0.3191M
December 31, 2017 0.3191M
September 30, 2017 0.3191M
June 30, 2017 0.3191M
March 31, 2017 0.3191M
December 31, 2016 0.3191M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 144.10M
Cue Biopharma, Inc. 7.754M
Faeth Therapeutics, Inc. 25.84M
Indaptus Therapeutics, Inc. 133.24M
Pyxis Oncology, Inc. 83.51M